[HTML][HTML] Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to …

JM Oh, BC Ahn - Theranostics, 2021 - ncbi.nlm.nih.gov
The advanced, metastatic differentiated thyroid cancers (DTCs) have a poor prognosis
mainly owing to radioactive iodine (RAI) refractoriness caused by decreased expression of …

[HTML][HTML] Radioiodine-refractory differentiated thyroid cancer: Molecular mechanisms and therapeutic strategies for radioiodine resistance

H Shen, R Zhu, Y Liu, Y Hong, J Ge, J Xuan… - Drug Resistance …, 2024 - Elsevier
Radioiodine-refractory differentiated thyroid cancer (RAIR-DTC) is difficult to treat with
radioactive iodine because of the absence of the sodium iodide transporter in the basement …

Redifferentiation of radioiodine-refractory thyroid cancers

C Buffet, J Wassermann, F Hecht… - Endocrine-Related …, 2020 - erc.bioscientifica.com
The management of radioiodine refractory thyroid cancers (RAIR TC) is challenging for the
clinician. Tyrosine kinase inhibitors classically prescribed in this setting can fail due to …

The Role of Notch3 in Cancer

Z Aburjania, S Jang, J Whitt, R Jaskula‐Stzul… - The …, 2018 - academic.oup.com
The Notch family is a highly conserved gene group that regulates cell‐cell interaction,
embryogenesis, and tissue commitment. This review article focuses on the third Notch family …

Notch-4 silencing inhibits prostate cancer growth and EMT via the NF-κB pathway

J Zhang, Y Kuang, Y Wang, Q Xu, Q Ren - Apoptosis, 2017 - Springer
Epithelial-mesenchymal transition (EMT) is implicated in the metastasis of human prostate
cancer (PCa). Notch signaling has been established as a regulator of EMT. Notch-4 has …

Notch signaling in thyroid cancer

R Guenter, Z Patel, H Chen - Notch Signaling in Embryology and Cancer …, 2021 - Springer
Thyroid cancer is the most common malignancy of the endocrine system with a steadily
rising incidence. The term “thyroid cancer” encompasses a spectrum of subtypes, namely …

Heterogeneity of vascular endothelial cells, de novo arteriogenesis and therapeutic implications in pancreatic neuroendocrine tumors

B Ren, JB Rose, Y Liu, R Jaskular-Sztul… - Journal of Clinical …, 2019 - mdpi.com
Arteriogenesis supplies oxygen and nutrients in the tumor microenvironment (TME), which
may play an important role in tumor growth and metastasis. Pancreatic neuroendocrine …

Notch signaling pathway in cancer: from mechanistic insights to targeted therapies

Q Shi, C Xue, Y Zeng, X Yuan, Q Chu, S Jiang… - … and Targeted Therapy, 2024 - nature.com
Notch signaling, renowned for its role in regulating cell fate, organ development, and tissue
homeostasis across metazoans, is highly conserved throughout evolution. The Notch …

Updates on the role of molecular alterations and NOTCH signalling in the development of neuroendocrine neoplasms

C von Arx, M Capozzi, E López-Jiménez… - Journal of clinical …, 2019 - mdpi.com
Neuroendocrine neoplasms (NENs) comprise a heterogeneous group of rare malignancies,
mainly originating from hormone-secreting cells, which are widespread in human tissues …

Molecular basis and targeted therapies for radioiodine refractory thyroid cancer

Q Yu, X Zhang, L Li, C Zhang, J Huang… - Asia‐Pacific Journal …, 2023 - Wiley Online Library
Patients diagnosed with radioiodine refractory thyroid cancer (RAIR‐TC) are not amenable
to novel 131I therapy due to the reduced expression of sodium iodide symporter (Na+/I …